EDGAR Filing Documents for 0001654954-19-013822

Form 8-K - Current report:

SEC Accession No. 0001654954-19-013822

Filing Date

2019-12-11

Accepted

2019-12-11 17:14:01

Documents

Period of Report

2019-12-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ndra_8k.htm	8-K	48712
2	FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK	ndra_ex41.htm	EX-4.1	56454
3	FORM OF WARRANT	ndra_ex42.htm	EX-4.2	89552
4	FORM OF SECURITIES PURCHASE AGREEMENT DATED DECEMBER 5, 2019	ndra_ex101.htm	EX-10.1	199441
5	FORM OF REGISTRATION RIGHTS AGREEMENT	ndra_ex102.htm	EX-10.2	98433
6	PRESS RELEASE	ndra_ex991.htm	EX-99.1	15895
7	IMAGE	ndra_ex991000.jpg	GRAPHIC	3359
	Complete submission text file	0001654954-19-013822.txt		514597

Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105

Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468

ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)